Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol

Published:1999-11 Issue:9 Volume:49 Page:1215-1225
ISSN:0277-9536
Container-title:Social Science & Medicine
language:en
Short-container-title:Social Science & Medicine

Author:

Walsh Vivien,Goodman Jordan

Publisher

Elsevier BV

Subject

History and Philosophy of Science,Health (social science)

Reference78 articles.

1. Science, Politics and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation;Abraham,1995

2. Taxol: clinical trials and current issues in development. Suffness M;Arbuck,1995

3. Parallel Convergence;Arnold,1986

4. Bean, M. 1997 Interview with the authors, 8 April

5. Technology transfer and the Federal laboratories: a midterm assessment of cooperative research;Berman;Policy Studies Journal,1995

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells;Cancer Cell International;2024-07-17

2. Paclitaxel – a Product of Fungal Secondary Metabolism or an Artefact?#;Planta Medica;2024-05-16

3. Traditional Ethnomedicinal Plants: Unveiling Rich Reservoirs of Bioactive Molecules for Drug Discovery and Development;Ethnomedicinal Plants for Drug Discovery;2024

4. Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing;Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery;2023-06-07

5. Exploring the potential of fungal endophytes: A quintessential source for novel secondary metabolites and beneficial aspects;Microbial Inoculants;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3